[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.87.121.0. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 881
Citations 0
Correction
May 1, 2013

Incomplete Conflict of Interest Disclosures in: Effects of Fructose vs Glucose on Regional Cerebral Blood Flow in Brain Regions Involved With Appetite and Reward Pathways

JAMA. 2013;309(17):1773. doi:10.1001/jama.2013.150

Incomplete Conflict of Interest Disclosures: In the Preliminary Communication entitled “Effects of Fructose vs Glucose on Regional Cerebral Blood Flow in Brain Regions Involved With Appetite and Reward Pathways” published in the January 2, 2013, issue of JAMA (2013;309[1]:63-70), information reported by the authors for the Conflict of Interest Disclosures section was inadvertently omitted. The text in that section should have read as follows: “All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Sinha reported receiving a grant from and being a consultant to the National Institutes of Health; and being a scientific advisory board member for Embera Neurotherapeutics. Dr Sherwin reported receiving grants from the National Institute of Diabetes and Digestive and Kidney Diseases and the Juvenile Diabetes Research Foundation; serving on scientific advisory boards for Amylin Corp, Merck, Pfizer, Janssen, and Insulet; serving on data and safety monitoring boards for Novartis and MannKind; being a consultant to Bristol-Myers Squibb, Eli Lilly, and McKinsey & Company; owning stock in Insulet; and receiving payment for lectures from Merck. Dr Page reported no disclosures.” This article has been corrected online.

×